TeleHealth platform provider SteadyMD has received an unspecified amount of venture funding from healthcare company AmerisourceBergen’s venture funding arm, AB Health Venture Fund. 

Post-funding, the companies are partnering to co-create and pilot a TeleHealth solution that employs the “Test to Treat” business model, covering patients' healthcare requirements at participating locations from the testing phase to dispensing treatment and medication. Through the partnership, patients can access SteadyMD’s platform at participating locations to receive Test to Treat options, including virtual consultations as needed.    

Participating pharmacies can also use the pilot program to facilitate patients obtaining Covid-19 oral antiviral therapies as needed. The pilot program will be rolled out across 130 retail pharmacies over the span of 12 weeks.